Abstract:
This invention is a method and apparatus for non-invasiveness in determining hematocrit, utilizing the frequency dependent electrical impedance characteristics of whole blood by electrically stimulating a patient body portion containing a vascular compartment with a current source over a range of frequencies. A hematocrit measurement system includes a signal generator and demodulator [SGD] (34) that sends an applied signal to an electrode pod (36) that applies a current to a limb of a patient. The electrode pod (36) receives resulting measured voltage signals and provides them to the SGD. The SGD provides to a personal computer [PC] (42) signals indicative of the current passing through the limb of the patient and the resulting voltage. The voltage and current may be measured for various frequencies over, for example, a range from about 10 kHz to about 10 MHz. The electrical impedance from the blood alone is isolated from the total limb impedance from the blood, tissue, bone, etc. by determining the difference between measurement at different blood volumes. The hematocrit is determined by the PC based on inphase and quadrature data provided by the SGD. A neural network (52) may be useful in determining the hematocrit from the blood impedance patterns.
Abstract:
The sphygmomanometry using sphygmomanometric means (72) is terminated with sphygmomanometry terminating means (84), when the value of |DM - DCP|/DCP is within the range of a preset reference value alpha for judgment, the DM representing a phase difference provided based on a monitoring blood value MBP determined with monitoring blood pressure value determining means (76) from a phase difference/blood pressure relationship in the step of initiating sphygmomanometry with the sphygmomanometric means (72) while the DCP representing an actual phase difference determined with phase difference computing means (80). Therefore, when a deviation of the pressure pulse wave/blood pressure relationship is not significant, the execution of unnecessary sphygmomanometry for redertermining the pressure pulse wave/blood pressure relationship can be dispensed with, thus reducing the frequency of sphygmomanometry using a cuff, which in turn reduces the burden on the living body.
Abstract:
Disclosed is an oscillometric method of determining basic haemodynamic parameters in a patient's arterial circulation. According to the proposed method, the parameters in question are determined from characteristic points (9, 10) of a recorded oscillometric signal (5) of the patient's arterial pulsogramme and the simultaneously recorded pressure fluctuation signal (4) from the measurement cuff (2). Also disclosed is a measurement system (3) for carrying out this method, comprising a unit to form the frequency characteristics of the arterial pulsogramme oscillometric signal or a device for calculating the continuous component of that signal.
Abstract:
The calibration device includes a controllable pneumatic pump (44), a pressure sensor (48), a computerized device (72) for determining when a representative number of blood volume change signals are substantially similar and thereafter generating a calibration signal. The calibration system also includes a device which changes the volume in the closed peumatic system by a predetermined calibrated amount in the presence of the calibration trigger signal. This volume changing device may be a series of valves (V1, V2) coupled by a chamber (50) having a known volumetric size or a positive displacement pump driven by a stepper motor. The calibration system also includes a computerized device for correcting representative blood volume change signals based on the pressure signals at each discrete level of cuff pressure as corrected by the calibration signals represented by detected pressure signals obtained substantially simultaneously with the change of the volume at each discrete level of cuff pressure.
Abstract:
A cardiac ablation catheter (10) includes a distal, energy delivering electrode (14) and at least one sensing electrode (16) proximal to the energy delivering electrode (14). The catheter communicates with an electrosurgical generator (22) which provides electrical energy, such as a radio frequency energy, to the distal energy (14). The sensing electrodes (16) communicate with a monitor (24) for recording electrical signals within the heart. One or more resistors (30) is positioned adjacent each sensing electrode (16), and in series with a conductor (20) associated with the sensing electrode (16), to reduce or eliminate any current tending to be emitted through the sensing electrodes (16) as a result of delivery of electrical current through the distal electrode (14).
Abstract:
A portable apparatus for the non-invasive, simultaneous, self-testing of fetal and maternal signals which comprises: a user display means (19) to indicate that the device is operational, an ultrasonic means (1) to detect fetal heart rate connected to the device, a detection means (15) for detecting a maternal input signal connected to the device, wherein the device has signal processing means (25) for simultaneously processing fetal heart rate and maternal input signals, and also has a communication linking means (27) for the simultaneous transmission of fetal heart rate and maternal input data to a remote output device.
Abstract:
Several techniques are provided for aiding in the discrimination of detected bilogical signals indicative of blood pressure from detected signals not indicative of blood pressure (e.g., noise). A threshold, based predominantly on a level of noise, is developed and used in the discrimination. A second threshold, based predominantly on levels of previously detected biological signals, is developed and additionally used to help discriminate the biological signals from noise. The biological signals are detected during a selected portion of a cardiac cycle, and additional signals detected outside of the selected portion of the cycle are applied to the detected signals. Another threshold may be developed based predominantly on a level of signals sensed by a transducer positioned to preferentially sense noise; the transducer is positioned so that the noise that it detects is related to noise that is detected during the detection of the bilogical signals. Blood pressure is measured during periodically scheduled measurement cycles, and a measurement cycle is suspended if noise exceeds a predeteremined level. The times at which the detected signals (i.e., the signals indicative of blood pressure and the signals not indicative of blood pressure) are processed during a given cardiac cycle are selected based at least in part on the pressure of the cuff. The biological signals indicative of blood pressure that are detected during a current measurement cycle are used to at least in part determine the times at which the detected signals will be processed during a succeeding measurement cycle.
Abstract:
A method and device for indirect, quantitative estimation of blood pressure attributes and similar variable physiological parameters utilizing noninvasive, indirect techniques. The method of practice includes (i) generating a sequence of signals which are quantitative dependent upon the variable parameter, (ii) transmitting and processing the signals within a computer system and associated neural network capable of generating a single output signal for the combined input signals, (ii) invasively determining an actual value for the parameter concurrent with the noninvasive generation of signals of the previous steps, (iv) applying weighting factors within the neural network at interconnecting nodes to force the output signal of the neural network to match the true value of the parameter as determined invasively, (v) recording the input signals, weighting factors and true value as training data within memory of the computer, and (vi) repeating the previous steps to develop sufficient training data to enable the neural network to accurately estimate parameter value upon future receipt of on-line input signals. Procedures are also described for preclassification of signals and artifact rejection. Following training of the neural network, further invasive measurement is unnecessary and the system is ready for diagnostic application and noninvasive estimation of parameter values.
Abstract:
The blood flow in the upper arm is obstructed by a blood flow obstruction bag (220) in a cuff (200) applied to the upper arm. The flow obstruction bag is provided with a front detecting bag (210) and rear one (230) on the up- and down-stream sides thereof, respectively, and a front sensor (110) and rear one (120) are provided for detecting pressure in respective detecting bags. Each sensor detects front pulse waves (Wf) and rear ones (Wb) respectively. Standard internal pressure in the cuff is controlled by a pneumatic pump (140) and a leak valve (150) controlled by the CPU (130). With every pulse wave monitored, the internal standard pressure in the cuff can be maintained at systolic phase pressure SP or diastolic phase pressure DP. A propagation speed of the pulse wave passing beneath the cuff whose internal pressure is maintained at the systolic phase pressure SP can be found from the time of delay SPdt of the rear pulse wave from the front pulse wave and is approximate to a blood flow velocity VH when the aorta is at high pressure. A blood flow velocity VL when the aorta is at low pressure is found when dividing the blood flow velocity VH by a given coefficient R. The rear pulse wave obtained when the standard internal pressure is maintained at the diastolic phase pressure DP becomes an approximate aortic wave. On the basis of the waveform of this approximate aortic wave, effective cross-sectional areas SH and SL of the blood flow are found and a blood flow quantity per unit pulse is calculated by multiplying the cross-sectional area by the blood flow velocity.
Abstract:
A method and system for analyzing diastolic heart sounds detected rom a patient's chest cavity during the diastolic portion of the heart cycle in order to identify a low level auditory component associated with turbulent blood flow in partially occluded coronary arteries. The system includes an acoustic transducer (1) coupled against the chest cavity of a patient using an ultrasonic acoustic gel and a pulse sensor device and a signal processor (7) and a diagnostic display (14). Heart sounds detected by the acoustic transducer (1) are amplified by a conventional low noise audio amplifier (2), resulting in an electrical heart sound signal (3). Electro-optical pulse detector and associated amplifier (4) provide an output signal based on occurrence of the patient's pulse. The signal is processed through threshold detector (5) to provide a timing reference signal (6) indicative of the occurence of each pulse.